STOCKHOLDERS DEFICIT (Details Narrative) - USD ($)		12 Months Ended
	Oct. 05, 2018	Apr. 30, 2022	Apr. 30, 2021
Common stock, Authorized			11,000,000
Consisting shares of preferred stock			1,000,000
Consisting shares of common stock			10,000,000
Shares issued, prefunded warrants		3,580,000
Warrants to the purchaser		2,575,500
Shares issued for the exercise of prefunded warrant, shares		3,580,000
Shares issued for the exercise of series A warrants		730,000
Shares issued for accrued expenses, shares		25,611
Shares issued for accrued expenses, value		$ 15,000
Shares issued for accrued expenses-related parties, shares		78,709
Shares issued for accrued expenses-related parties, value		$ 40,000
Shares issued for a debt discount, shares		100,000
Shares issued for a debt discount, value		$ 14,091
Warrants to the placement agent		337,500
Offering costs		$ 349,150
Warrants granted		529,852
Sale of common stock		6,493,000
Warrants granted, prefunded		3,580,000
Warrants description		The remaining warrants have a 5 year life and 2,575,500 of the warrants were issued with a $0.80 exercise price while the other 337,500 were issued with a $1.00 exercise price.
Warrants modified the terms of description		the Company modified the terms of the 2,575,500 warrants which resulted in the exercise price changing from $0.80 to $0.0001.
Description of Common Stock Reserved		Combined with the 21,204,682 common shares outstanding at April 30, 2022, all authorized common shares have been issued or reserved for issuance of outstanding warrants, stock options, and convertible notes payable and no common shares are available for share issuances other than those shares included in the reserves
Settlement of derivative liabilities in debt conversions			$ 22,511,164
Common stock, Authorized		200,000,000	200,000,000
Preferred stock, Authorized		1,000,000	1,000,000
GS Pledge Agreement [Member]
Outstanding shares option	2,000,000
Shares, outstanding, canceled	2,000,000
Weghted Average Exercise Price	$ 0.08
Weighted Average Remaining Contractual Life	10 years
Accrued expenses [Member] | Stock Issuances [Member]
Accrued interest payable		$ 4,490	$ 301,943
Conversion of convertible notes principal amount		$ 149,444	$ 1,618,394
Common stock shares issued for cash, shares		170,000
Common stock shares issued for cash, amount		$ 3,000,000
Shares issued for accrued expenses, shares		17,953,041	1,916,358
Common stock shares issued for conversion of convertible note, shares		6,433,743	1,525,583
Common stock shares issued for conversion of convertible note, value		$ 154,438	$ 1,932,365
Payment for fees		$ 504	$ 12,028
Common stock shares issued upon conversion of debt, shares		17,754
Common stock shares issued for conversion of convertible note		6,817,224	388,775
Common stock shares issued for conversion, value		$ 74,989	$ 4,277
Common stock shares issued for conversion, principal value			$ 4,277
Shares for consulting services, shares			2,000
Shares for consulting services, value			$ 34,000
August 16, 2021 [Member]
Consisting shares of common stock		200,000,000
Common stock, Authorized		201,000,000
Preferred stock, Authorized		1,000,000
Common stock, description		on August 16, 2021, the Company approved an amendment to its Articles of Incorporation to increase the number of its authorized shares of common stock from 10,000,000 to 200,000,000.
Ownership percentage		50.10%
Series A, Preferred Stock
Common stock, voting rights, Description		Shareholders owning in excess of 50.1% of the outstanding shares of voting common stock of the Company executed a written consent approving the amendment
Common stock, description		the 33,325,000 warrants granted with the sale of Series A preferred stock, 14,399,500 have an exercise price of $0.0001, 17,575,500 have an exercise price of $0.10, and 1,350,000 have an exercise price of $0.125. All 33,325,000 warrants were granted with a 5 year life
Series B, Preferred Stock
Sale of common stock		6,493,000
Sale of warrants		33,325,000
Voting right		$ 1,000
Conversion price		$ 0.10
Designated shares		1,500
Reduce the conversion price per share		$ 0.05
Offering costs		$ 206,650
Common stock, voting rights, Description		issued 1,500 shares of Series B preferred stock (plus 31,975,000 warrants, see Warrants below) for cash of $1,500,000. In conjunction with the stock issued for cash, the Company also issued 1,350,000 warrants